Evidence map›Paper›PMID 35130295›Full record

ArticlePloS one2022

TBISTAT: An open-source, wireless portable, electrochemical impedance spectroscopy capable potentiostat for the point-of-care detection of S100B in plasma samples.

Francisco Burgos-Flórez, Alexander Rodríguez, Eliana Cervera, Valtencir Zucolotto, Marco Sanjuán, Pedro J Villalba

Open access · goldAbstract readValidation Study
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Francisco Burgos-FlórezDepartment of Medicine, Biotechnology Research Group, Universidad del Norte, Barranquilla, Colombia.
Alexander RodríguezDepartment of Medicine, Biotechnology Research Group, Universidad del Norte, Barranquilla, Colombia.
Eliana CerveraDepartment of Medicine, Biotechnology Research Group, Universidad del Norte, Barranquilla, Colombia.
Valtencir ZucolottoGNano-Nanomedicine and Nanotoxicology Group, São Carlos Institute of Physics, University of São Paulo, São Carlos, São Paulo, Brazil.
Marco SanjuánDepartment of Mechanical Engineering, Rational Use of Energy and Preservation of the Environment Group (UREMA), Universidad del Norte, Barranquilla, Colombia.
Pedro J VillalbaDepartment of Medicine, Biotechnology Research Group, Universidad del Norte, Barranquilla, Colombia.ORCID 0000-0003-3015-0299
Universidad del Norte · COUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point-of-Care (POC) testing for biomarker detection demands techniques that are easy to use, readily available, low-cost, and with rapid response times. This paper describes the development of a fully open-source, modular, wireless, battery-powered, smartphone-controlled, low-cost potentiostat capable of conducting electrochemical impedance spectroscopy for the electrochemical detection of the S100B protein captured in an ANTI-S100B functionalized thin-film gold interdigitated electrode platform to support traumatic brain injury diagnosis and treatment. EIS results from the developed potentiostat were validated with a commercial benchtop potentiostat by comparing impedance magnitude and phase values along the EIS frequency range. In addition, an experimental design was performed for detecting S100B in spiked human plasma samples with S100B concentrations of clinical utility, and a calibration curve was found for quantifying S100B detection. No statistically significant differences were found between EIS results from the developed potentiostat and the commercial potentiostat. Statistically significant differences in the changes in charge transfer resistance signal between each tested S100B concentration (p < 0.05) were found, with a limit of detection of 35.73 pg/mL. The modularity of the proposed potentiostat allows easier component changes according to the application demands in power, frequency excitation ranges, wireless communication protocol, signal amplification and transduction, precision, and sampling frequency of ADC, among others, when compared to state-of-the-art open-source EIS potentiostats. In addition, the use of minimal, easy acquirable open-source hardware and software, high-level filtering, accurate ADC, Fast Fourier Transform with low spectral leakage, wireless communication, and the simple user interface provides a framework for facilitating EIS analysis and developing new affordable instrumentation for POC biosensors integrated systems.

Indexed as

Biosensing TechniquesDielectric SpectroscopyPoint-of-Care SystemsBlood Chemical AnalysisBrain Injuries, TraumaticColombiaElectric ImpedanceElectrochemical TechniquesElectrodesGoldHumansPotentiometryS100 Calcium Binding Protein beta SubunitSoftwareTrauma Severity IndicesWireless TechnologyGoldS100B protein, humanS100 Calcium Binding Protein beta Subunit

Identifiers

PMID35130295
PMCPMC8820642
OpenAlexW4210661985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.